Tin tức & Cập nhật

Treatment with mirikizumab results in significant improvements in clinical, endoscopic, and histologic outcomes during induction and maintenance phases in patients with Crohn’s disease (CD) or ulcerative colitis (UC), according to an updated meta-analysis of randomized controlled trials (RCTs).

Treatment with either vedolizumab or ustekinumab delivers significant and meaningful benefits to patients with Crohn’s disease (CD), but each has its distinct therapeutic profile with complementary advantages, reports a real-world study presented at CCC 2026.

Peppermint oil or peppermint sweets appear to do little in terms of relieving pain in children with irritable bowel syndrome (IBS) or functional abdominal pain–not otherwise specified, as shown in a study.

The use of intra-arterial (IA) alteplase following a successful endovascular thrombectomy (EVT) improves 90-day functional outcome in patients with large-vessel occlusion (LVO) acute ischaemic stroke compared with EVT-alone, according to the CHOICE 2* trial presented at ISC 2026.

Three months of romosozumab followed by 9 months of denosumab works just as well as 12 months of romosozumab for increasing bone mass in postmenopausal women at high risk of fracture, as shown in an open-label, noninferiority trial.

Results of the BASIS trial demonstrate the efficacy and safety of once-weekly SC marstacimab prophylaxis up to 12 months in male adolescents and adults with severe haemophilia A* (HA) or severe-to-moderately-severe haemophilia B** (HB) with no detectable or documented history of inhibitors against factors VIII or IX, and who were receiving on-demand (OD) or routine prophylaxis (RP) prior to enrolment.

Initiating antiretroviral therapy (ART) with the fixed-dose combination of bictegravir, emtricitabine, and tenofovir alafenamide on the same day of HIV diagnosis appears to promote a high level of engagement in care in Taiwan.

The use of inhaled ciclesonide provides no additional benefit to vaccinated adults exposed to Omicron variants of SARS-CoV-2 in fast-tracking their recovery from acute symptoms, a study has shown.

Getting a COVID-19 shot prior to or during pregnancy reduces the risks of severe maternal disease outcomes and preterm birth, and this protection remains consistent across different variant periods, according to a study from Canada.